Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Standard Biotools (LAB) Goodwill (2016 - 2025)

Historic Goodwill for Standard Biotools (LAB) over the last 12 years, with Q1 2025 value amounting to $111.7 million.

  • Standard Biotools' Goodwill rose 512.85% to $111.7 million in Q1 2025 from the same period last year, while for Mar 2025 it was $111.7 million, marking a year-over-year increase of 512.85%. This contributed to the annual value of $111.3 million for FY2024, which is 468.41% up from last year.
  • According to the latest figures from Q1 2025, Standard Biotools' Goodwill is $111.7 million, which was up 512.85% from $111.3 million recorded in Q4 2024.
  • Over the past 5 years, Standard Biotools' Goodwill peaked at $111.7 million during Q1 2025, and registered a low of $106.1 million during Q3 2022.
  • For the 5-year period, Standard Biotools' Goodwill averaged around $106.9 million, with its median value being $106.3 million (2023).
  • As far as peak fluctuations go, Standard Biotools' Goodwill soared by 473890.91% in 2021, and later tumbled by 33.73% in 2022.
  • Quarter analysis of 5 years shows Standard Biotools' Goodwill stood at $106.4 million in 2021, then decreased by 0.12% to $106.3 million in 2022, then increased by 0.06% to $106.3 million in 2023, then increased by 4.68% to $111.3 million in 2024, then increased by 0.38% to $111.7 million in 2025.
  • Its Goodwill stands at $111.7 million for Q1 2025, versus $111.3 million for Q4 2024 and $106.3 million for Q3 2024.